BMS and Gilead continue their fight over Yescarta patent infringement; Canadian researchers develop multidrug-resistant, bacteria-repelling plastic coating; Healthcare.gov floods with last-minute sign-ups on final day of enrollment for 2020 plans.
Gilead said it will appeal the $752 million award handed down against the company on Friday in its ongoing fight with Bristol-Myers Squibb (BMS), according to Reuters. A Los Angeles jury ruled against Gilead in a patent dispute over Yescarta (axicabtagene ciloleucel; Gilead/Kite Pharma), a chimeric antigen receptor T-cell treatment used as a cancer immunotherapy. Currently, Juno Therapeutics, a division of BMS, holds the patent under an exclusive licensing deal from Memorial Sloan Kettering Cancer Center.
In an effort to combat antibiotic resistance and multidrug-resistant bacteria, scientists from McMaster University have developed a plastic coating that can repel bacteria, according to CNN. The team of researchers were also able to show how their innovation can block methicillin-resistant Staphylococcus aureus and Pseudomans due to microscopic wrinkles on its surface. The technology has a wide variety of applications, including protecting food and shrink-wrapping surfaces in healthcare settings. Upwards of 35,000 people dying each year from drug-resistant infections.
The final day of open enrollment for Healthcare.gov plans, December 15, saw the site seize, which prevented people from signing up for health coverage under plans that begin January 1, according to The Hill. Almost 100,000 people faced a similar problem on the first enrollment day this year. Now, however, several Democratic lawmakers—including Senator Elizabeth Warren, D-Massachusetts, and Senator Bob Casey, D-Pennsylvania—are asking for a sign-up extension, citing the technical problems. Enrollment is already down 6% compared with the same time last year.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More